Clinical outcomes for Medicare recipients with early-onset breast cancer: An analysis of the National Inpatient Sample.

T Tony Elias (2Temple University, Philadelphia, United States) D Danielle Claire Thor (Jefferson Health New Jersey, Stratford, NJ) V Vineet Polineni (1Jefferson Health - New Jersey, Stratford, United States) B Ben Brik (1Jefferson Health - New Jersey, Stratford, United States) M Mahija Cheekati (3Ochsner Clinic Foundation, New Orleans, United States)

Abstract

e23355 Background: Despite recent global decreases in overall cancer incidence, the incidence of early-onset breast cancer (EOBC) is steadily increasing globally. Limited data is available on the comorbid correlations for this unfortunately expanding population. We sought to examine the national inpatient sample database to describe in-hospital outcomes among Medicare recipients with EOBC. Methods: Data were extracted from the National Inpatient Sample (NIS) Database for 2019 and 2020. The NIS was searched for hospitalizations of adult patients with EOBC, defined as all-cause breast cancer in patients 50 years old or younger. We then examined the outcomes of patients who were noted to be active Medicare recipients. Multivariate logistic was used to adjust for confounders. The primary outcome was inpatient mortality and secondary outcomes were annotated accordingly. SPSS software was used for statistical analysis, and all results were powered to p < 0.001. Results: This study included 10,764 patients with EOBC, of which 997 (9.26%) were Medicare users. Multivariate regression showed that Medicare patients with EOBC had higher inpatient mortality (OR 1.104, CI 1.070-1.139, p < 0.001). On secondary analysis, Medicare patients with EOBC were more likely to have systemic lupus erythematosus (OR 1.254, CI 1.118-1.407), anemia (OR 1.128, CI 1.115-1.141), thrombocytopenia (OR 1.143, CI 1.114-1.173), hypertension (OR 1.385, CI 1.301-1.475), chronic kidney disease (OR 1.473, CI 1.358-1.598), acute renal failure (OR 1.159, CI 1.126-1.192), pancreatitis (OR 1.092, CI 1.018-1.172), pericarditis (OR 1.108, CI 1.060-1.157), intracranial hemorrhage (OR 1.288, CI 1.088-1.373), severe liver disease (OR 1.137, CI 1.119-1.155), diabetes mellitus (OR 1.267, CI 1.128-1.423), peptic ulcer disease (OR 1.155, CI 1.074-1.242), obstructive sleep apnea (OR 1.200, CI 1.140-1.263), all-cause arrhythmias (OR 1.153, CI 1.103-1.206), all-cause shock (OR 1.112, CI 1.041-1.188), all-cause heart block (OR 1.294, CI 1.103-1.519), all-cause sepsis (OR 1.134, CI 1.115-1.154), all-cause coagulopathy (OR 1.144, CI 1.102-1.188), all-cause heart failure (OR 1.254, CI 1.191-1.321), all-cause stroke (OR 1.245, CI 1.176-1.318), and all-cause myocardial infarction (OR 1.299, CI 1.174-1.437). Conclusions: In this nationally representative, population‐based retrospective cohort study, Medicare recipients with EOBC were associated with higher mortality and worse outcomes.

Article Details

Volume / Issue Vol. 43, Issue 16_suppl
Published June 01, 2025
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (5)

T

Tony Elias

2Temple University, Philadelphia, United States

D

Danielle Claire Thor

Jefferson Health New Jersey, Stratford, NJ

V

Vineet Polineni

1Jefferson Health - New Jersey, Stratford, United States

B

Ben Brik

1Jefferson Health - New Jersey, Stratford, United States

M

Mahija Cheekati

3Ochsner Clinic Foundation, New Orleans, United States